INTERNATIONAL PATENT: DOMPE' FARMACEUTICI S.P.A. FILES APPLICATION FOR "NERVE GROWTH FACTOR AND METHODS OF USE THEREOF FOR NEURODEVELOPMENTAL DISABILITIES ASSOCIATED WITH NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY"

GENEVA, Oct. 4 -- DOMPE' FARMACEUTICI S.P.A. (Via San Martino, 1220122 Milano) filed a patent application (PCT/IB2025/053216) for "NERVE GROWTH FACTOR AND METHODS OF USE THEREOF FOR NEURODEVELOPMENTAL DISABILITIES ASSOCIATED WITH NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY" on Mar 26, 2025. With publication no. WO/2025/202941, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARAMINI, Andrea (Via San Martino, 1220122 Milano), BRANDOLINI, Laura (Via San Martino, 1220122 Milano), BOCCELLA, Serena (Via San Martino, 1220122 Milano...